Neurocrine Biosciences, Inc. To Present At The CIBC 16th Annual Healthcare Conference

SAN DIEGO, Nov. 7 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that the Company will present at the CIBC World Markets 16th Annual Healthcare Conference on Wednesday, November 9, 2005 at 11:30AM Eastern Standard Time (EST) / 8:30AM Pacific Standard Time (PST). The presentation will be simultaneously webcast and can be accessed on the Company’s website at http://www.neurocrine.com

Gary Lyons, President and Chief Executive Officer of Neurocrine will present an overview of the Company and provide an update on Neurocrine’s broad development pipeline and research programs.

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Woodworth or Elizabeth Foster. A replay will become available approximately three hours after the live event concludes. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. The presentation will be archived until Wednesday, November 23, 2005.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company’s website via the Internet at http://www.neurocrine.com

Neurocrine Biosciences, Inc.

CONTACT: Claudia Woodworth or Elizabeth Foster, both of NeurocrineBiosciences, +1-858-617-7600

MORE ON THIS TOPIC